News

New ‘sprouting’ Recoffee shampoo made from 16 cups of coffee

BY Antoinette Alexander

TAIPEI, Taiwan — Does your empty shampoo bottle grow into a tree? O'right's Tree in the Bottle is the first shampoo to do just that.

It features a biodegradable bottle — the first of its kind, according to the company — made from a plastic-like starch, which is processed from fruit, plant and vegetable waste. Once you have finished with the shampoo, then plant the empty bottle. Each bottle comes preloaded with tree seeds in a plug at the bottom of the bottle, and in a matter of months, the bottle will biodegrade and the seeds inside will sprout up into a tree.

What's more, the Taiwan-based green enterprise O'right has recently introduced Recoffee, a shampoo made from 16 cups of ground coffee. O'right produced shampoo and hair-conditioning products by extracting the oil from recycled coffee grounds collected from Starbucks and other coffee shops in Taiwan.

According to O'right founder and chairperson, Steven Ko, 14,000 cups of coffee are consumed around the world every second, which results in a total of 22 million kilograms of discarded coffee grounds every year. Each liter of Recoffee shampoo uses the coffee grounds from 16 medium cups of coffee. To be exact, 16 cups of medium-sized Starbucks coffee produce about 320 grams of coffee grounds, but only 5 grams of coffee oil can be extracted from these coffee grounds. The extracted coffee oil must then be further processed before it is added into a formula to produce 1,000 milliliters of Recoffee shampoo, the company stated.

Recoffee shampoo's biodegradable bottle base also doubles as a planter for coffee seedlings. Like all of O'right's Tree in the Bottle products, the Recoffee bottle can be buried in the ground and will eventually grow into a new coffee tree.

Home to the first GMP-certified green cosmetics plant in Asia, the company manufactures all of its products using 100% solar and wind energy, along with waste-water-management systems that enable the reuse of water resources, the company stated.

O'right has developed more than 110 products. It also has more than 200 employees, and it counts 10,000 salons in 20 countries as its clients.
 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Costco sees 9% boost in Q4 sales

BY Antoinette Alexander

ISSAQUAH, Wash. — Costco announced on Wednesday a rise in sales and same-store sales for the fourth quarter.

Net sales for the quarter were $34.75 billion, an increase of 9% from $31.77 billion in fiscal 2013. Same-store sales for the total company increased 6%, while U.S. same-store sales also rose 6%.

Net income for the quarter was $697 million, or $1.58 per diluted share, compared with $617 million, or $1.40 per diluted share, in the year-ago period.

Fiscal year 2014 sales totaled $110.21 billion, an increase of 7%. Same-store sales increased 4% for the company and 5% in the United States.

Net income for the fiscal year was $2.06 billion, or $4.65 per diluted share, compared with $2.04 billion, or $4.63 per diluted share, in fiscal year 2013. Net income last year was positively impacted by a $62 million tax benefit in connection with the portion of the special cash dividend paid in December 2012 to the company 401(k) plan participants.
 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Striverdi Respimat from Boehringer Ingelheim now available

BY Ryan Chavis

Image: Boehringer Ingelheim GmbH

RIDGEFIELD, Conn. — Boehringer Ingelheim on Wednesday announced that its Striverdi Respimat (olodaterol) inhalation spray in 5-mcg dosage strength is now available by prescription in pharmacies across the United States. The medicine is a once-daily treatment for airflow obstruction in patients dealing with chronic obstructive pulmonary disease, including chronic bronchitis and/or emphysema. It should not be used to treat asthma or acute deteriorations of COPD, according to the company.
 
"For over a half century, Boehringer Ingelheim has been a leader in discovering and developing new therapies for respiratory diseases. We're proud to build upon our respiratory heritage by bringing Striverdi Respimat to market as a new COPD maintenance treatment option," said Kathleen M. Dowd, SVP, marketing, Boehringer Ingelheim Pharmaceuticals. "Approximately 15 million Americans have been told by a healthcare provider that they have COPD, and we believe Striverdi Respimat will be a welcome option for providers and patients alike."
 
The company will offer a savings card that will allow most eligible patients to obtain the medication at no cost for a limited time, depending on their insurance coverage. The savings card can be found at Striverdi.com and can be activated at any pharmacy, the company said. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?